Cytek Biosciences Quote - CTKB

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

6.56

Bid

6.45

Offer

6.87

Volume

414,852

6.455 Day's Range 6.77

4.66 52 Week Range 9.87

Market Cap

844.998M

Previous Close

6.73

Open

6.72

Last Trade

561

6.56

(priorref)

Last Trade Time

Financial Volume

US$ 2,747,199

VWAP

6.6221

Average Volume (3m)

686,630

Shares Outstanding

128,810,614

Dividend Yield

PE Ratio

-69.57

Earnings Per Share (EPS)

-0.09

Revenue

193.02M

Net Profit

-12.15M

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-co... Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Show more

Sector

Lab Analytical Instruments

Industry

Lab Analytical Instruments

Website

www.cytekbio.com

Headquarters

Dover, Delaware, USA

Founded

Cytek Biosciences Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker CTKB. The last closing price for Cytek Biosciences was US$6.73. Over the last year, Cytek Biosciences shares have traded in a share price range of US$ 4.66 to US$ 9.87.

Cytek Biosciences currently has 128,810,614 shares in issue. The market capitalisation of Cytek Biosciences is US$866.90 million. Cytek Biosciences has a price to earnings ratio (PE ratio) of -69.57.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.12	-1.79640718563	6.68	6.89	6.415	606882	6.67295989	CS
4	-0.59	-8.25174825175	7.15	7.15	5.68	603677	6.50178743	CS
12	1.21	22.6168224299	5.35	7.63	4.66	686630	6.00026888	CS
26	0.64	10.8108108108	5.92	7.63	4.66	642125	5.85969951	CS
52	-1.1	-14.3603133159	7.66	9.87	4.66	683312	6.68172059	CS
156	-11.99	-64.6361185984	18.55	19.245	3.8	813421	9.27915212	CS
260	-13.54	-67.3631840796	20.1	28.7	3.8	751722	9.86076172	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
LAESSEALSQ Corporation	US$ 1.1406 (99.75%)	223.5M
AMPGAmplitech Group Inc	US$ 1.9001 (91.52%)	200.42M
CADLCandel Therapeutics Inc	US$ 7.7401 (67.90%)	99.69M
JZXNJiuzi Holdings Inc	US$ 1.792 (60.00%)	2.55M
LDTCLeddarTech Holdings Inc	US$ 1.81 (49.59%)	75.05M
SFHGSamfine Creation Holdings Group Ltd	US$ 3.04 (-85.59%)	10.28M
CLRBCellectar Biosciences Inc	US$ 0.3039 (-76.26%)	38.21M
QTTBQ32 Bio Inc	US$ 6.0291 (-75.30%)	3.44M
TFFPTFF Pharmaceuticals Inc	US$ 0.1639 (-45.78%)	3.54M
MARXMars Acquisition Corporation	US$ 7.24 (-33.33%)	55.08k
RGTIRigetti Computing Inc	US$ 7.38 (13.71%)	307.28M
LAESSEALSQ Corporation	US$ 1.1406 (99.75%)	223.5M
AMPGAmplitech Group Inc	US$ 1.9001 (91.52%)	200.42M
NVDANVIDIA Corporation	US$ 139.31 (3.14%)	182.43M
LCIDLucid Group Inc	US$ 2.44 (3.39%)	110.58M